Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1183

1.

Factors influencing herpes simplex virus type 2 infection among females in Enugu, Enugu State, Nigeria.

Ojinmah UR, Ozoh GA, Onyekonwu CL.

Niger J Med. 2014 Apr-Jun;23(2):130-41.

PMID:
24956686
[PubMed - indexed for MEDLINE]
2.

Impact of asymptomatic herpes simplex virus type 2 infection on mucosal homing and immune cell subsets in the blood and female genital tract.

Shannon B, Yi TJ, Thomas-Pavanel J, Chieza L, Janakiram P, Saunders M, Tharao W, Huibner S, Remis R, Rebbapragada A, Kaul R.

J Immunol. 2014 Jun 1;192(11):5074-82. doi: 10.4049/jimmunol.1302916. Epub 2014 Apr 23.

PMID:
24760150
[PubMed - indexed for MEDLINE]
3.

Helicase-primase inhibitor pritelivir for HSV-2 infection.

Burrel S, Rouard C, Boutolleau D.

N Engl J Med. 2014 Apr 24;370(17):1663-4. doi: 10.1056/NEJMc1402071. No abstract available.

PMID:
24758629
[PubMed - indexed for MEDLINE]
Free Article
4.

[Anti-herpetic effect of photodynamic action in an in vitro experiment].

Makarov OV, Khashukaeva AZ, Svitich OA, Markova ÈA, Khlynova SA, Labzhinov PA, Zverev VV.

Zh Mikrobiol Epidemiol Immunobiol. 2014 Jan-Feb;(1):48-55. Russian.

PMID:
24738294
[PubMed - indexed for MEDLINE]
5.

Pediatric herpes simplex virus infections: an evidence-based approach to treatment.

Sanders JE, Garcia SE.

Pediatr Emerg Med Pract. 2014 Jan;11(1):1-19; quiz 19. Review.

PMID:
24649621
[PubMed - indexed for MEDLINE]
6.

Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection.

Johnston C, Zhu J, Jing L, Laing KJ, McClurkan CM, Klock A, Diem K, Jin L, Stanaway J, Tronstein E, Kwok WW, Huang ML, Selke S, Fong Y, Magaret A, Koelle DM, Wald A, Corey L.

J Virol. 2014 May;88(9):4921-31. doi: 10.1128/JVI.03285-13. Epub 2014 Feb 19.

PMID:
24554666
[PubMed - indexed for MEDLINE]
7.

Herpes simplex virus 2 : a boon to develop other sexually transmitted infections.

Chopra S, Devi P, Devi B.

J Indian Med Assoc. 2013 Apr;111(4):236-8.

PMID:
24475553
[PubMed - indexed for MEDLINE]
8.

Antiviral activity of genital tract secretions after oral or topical tenofovir pre-exposure prophylaxis for HIV-1.

Herold BC, Dezzutti CS, Richardson BA, Marrazzo J, Mesquita PM, Carpenter C, Huber A, Louissaint N, Marzinke MA, Hillier SL, Hendrix CW.

J Acquir Immune Defic Syndr. 2014 May 1;66(1):65-73. doi: 10.1097/QAI.0000000000000110.

PMID:
24457633
[PubMed - indexed for MEDLINE]
9.

Helicase-primase inhibitor pritelivir for HSV-2 infection.

Wald A, Corey L, Timmler B, Magaret A, Warren T, Tyring S, Johnston C, Kriesel J, Fife K, Galitz L, Stoelben S, Huang ML, Selke S, Stobernack HP, Ruebsamen-Schaeff H, Birkmann A.

N Engl J Med. 2014 Jan 16;370(3):201-10. doi: 10.1056/NEJMoa1301150.

PMID:
24428466
[PubMed - indexed for MEDLINE]
Free Article
10.

HSV-2 incidence by sex over four age periods to age 38 in a birth cohort.

Dickson N, Righarts A, van Roode T, Paul C, Taylor J, Cunningham AL.

Sex Transm Infect. 2014 May;90(3):243-5. doi: 10.1136/sextrans-2013-051235. Epub 2013 Dec 13.

PMID:
24337730
[PubMed - indexed for MEDLINE]
11.

Incident herpes simplex virus type 2 infection increases the risk of subsequent episodes of bacterial vaginosis.

Masese L, Baeten JM, Richardson BA, Bukusi E, John-Stewart G, Jaoko W, Shafi J, Kiarie J, McClelland RS.

J Infect Dis. 2014 Apr 1;209(7):1023-7. doi: 10.1093/infdis/jit634. Epub 2013 Nov 22.

PMID:
24273042
[PubMed - indexed for MEDLINE]
12.

Etiology of genital ulcer disease and association with HIV infection in Malawi.

Phiri S, Zadrozny S, Weiss HA, Martinson F, Nyirenda N, Chen CY, Miller WC, Cohen MS, Mayaud P, Hoffman IF.

Sex Transm Dis. 2013 Dec;40(12):923-8. doi: 10.1097/OLQ.0000000000000051.

PMID:
24220352
[PubMed - indexed for MEDLINE]
13.

Prevalence of HIV, human papillomavirus type 16 and herpes simplex virus type 2 among female sex workers in Guinea and associated factors.

Aho J, Koushik A, Coutlée F, Diakité SL, Rashed S.

Int J STD AIDS. 2014 Mar;25(4):280-8. doi: 10.1177/0956462413500242. Epub 2013 Aug 28.

PMID:
24216036
[PubMed - indexed for MEDLINE]
14.

Treg depletion attenuates the severity of skin disease from ganglionic spread after HSV-2 flank infection.

Fernandez MA, Yu U, Zhang G, White R, Sparwasser T, Alexander SI, Jones CA.

Virology. 2013 Dec;447(1-2):9-20. doi: 10.1016/j.virol.2013.08.027. Epub 2013 Sep 13.

PMID:
24210095
[PubMed - indexed for MEDLINE]
15.

An indole alkaloid from a tribal folklore inhibits immediate early event in HSV-2 infected cells with therapeutic efficacy in vaginally infected mice.

Bag P, Ojha D, Mukherjee H, Halder UC, Mondal S, Chandra NS, Nandi S, Sharon A, Sarkar MC, Chakrabarti S, Chattopadhyay D.

PLoS One. 2013 Oct 22;8(10):e77937. doi: 10.1371/journal.pone.0077937. eCollection 2013.

PMID:
24167591
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Single dose of glycoprotein K (gK)-deleted HSV-1 live-attenuated virus protects mice against lethal vaginal challenge with HSV-1 and HSV-2 and induces lasting T cell memory immune responses.

Iyer AV, Pahar B, Chouljenko VN, Walker JD, Stanfield B, Kousoulas KG.

Virol J. 2013 Oct 28;10:317. doi: 10.1186/1743-422X-10-317.

PMID:
24165088
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Behavioral interventions for improving condom use for dual protection.

Lopez LM, Otterness C, Chen M, Steiner M, Gallo MF.

Cochrane Database Syst Rev. 2013 Oct 26;10:CD010662. doi: 10.1002/14651858.CD010662.pub2. Review.

PMID:
24163112
[PubMed - indexed for MEDLINE]
18.

Herpes simplex virus 2-induced activation in vaginal cells involves Toll-like receptors 2 and 9 and DNA sensors DAI and IFI16.

Triantafilou K, Eryilmazlar D, Triantafilou M.

Am J Obstet Gynecol. 2014 Feb;210(2):122.e1-122.e10. doi: 10.1016/j.ajog.2013.09.034. Epub 2013 Sep 28.

PMID:
24080302
[PubMed - indexed for MEDLINE]
19.

Recalcitrant pseudotumoral anogenital herpes simplex virus type 2 in HIV-infected patients: evidence for predominant B-lymphoplasmocytic infiltration and immunomodulators as effective therapeutic strategy.

Sbidian E, Battistella M, Legoff J, Lafaurie M, Bézier M, Agbalika F, Simon F, Bouscarat F, Cayuela JM, Carcelain G, Houhou N, Bagot M, Molina JM, Janier M, Bachelez H.

Clin Infect Dis. 2013 Dec;57(11):1648-55. doi: 10.1093/cid/cit592. Epub 2013 Sep 24.

PMID:
24065320
[PubMed - indexed for MEDLINE]
20.

Topical application of polyethylenimine as a candidate for novel prophylactic therapeutics against genital herpes caused by herpes simplex virus.

Hayashi K, Onoue H, Sasaki K, Lee JB, Kumar PK, Gopinath SC, Maitani Y, Kai T, Hayashi T.

Arch Virol. 2014 Mar;159(3):425-35. doi: 10.1007/s00705-013-1829-x. Epub 2013 Sep 18.

PMID:
24046087
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk